ERBA Diagnostics (ERB) Reports In-Line Q1 EPS

ERBA Diagnostics (NYSE: ERB) reported Q1 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $12.6 million versus the consensus estimate of $8.1 million.

For earnings history and earnings-related data on ERBA Diagnostics (ERB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery